Our attorneys have filed a mass tort lawsuit on behalf of sufferers who does xarelto commercial took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, including the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use – and failure to accomplish so may possibly be grounds for compensation. Our lawyers are functioning hard to obtain those hurt by the drug the compensation they’re entitled to.
While bleeding is actually a widespread complication linked with anticoagulants, it has been alleged that Xarelto is much more harmful than traditional blood thinners simply because no antidote exists to reverse its blood-thinning effects. This means that, inside the event of an emergency, sufferers may be at danger for irreversible bleeding difficulties, which includes life-threatening internal and gastrointestinal hemorrhaging.
Should you or even a loved one particular suffered a significant bleeding occasion after taking Xarelto, you may have legal recourse. For far more information, get in touch with us today to possess your case reviewed, free of charge of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future medical bills, lost wages, discomfort and suffering and, in cases of death, funeral expenses. Furthermore, they may be in search of punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the event of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to critical bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.